-
Melanoma Research Alliance advances personalized immunotherapies
A $900,000 Team Science grant will advance collaboration and innovation in immunotherapies for melanoma at Dana-Farber.
-
Sajni Fund raises vital funds for rare pediatric cancer research
Funds raised help to advance personalized immunotherapy for DIPG, a rare and aggressive pediatric brain tumor.
-
The Dana-Farber Campaign: The promise of personalized cancer vaccines
Funds raised through The Dana-Farber campaign are expanding the benefits of personalized cancer vaccines pioneered here.
-
International Myeloma Society
Mohammad Rashidian, PhD, received The International Myeloma Society and Paula and Rodger Riney Foundation Translational Research Award. He will use his $250,000 grant to empower investigations to address the challenge of disease relapse in patients treated with a specific type of CAR T-cell therapy. Such studies hold great promise in extending the efficacy of this…
-
LUNGevity Foundation
With grants totaling $400,000 from LUNGevity Foundation, Jaclyn LoPiccolo, MD, PhD, is researching prediction of genetic lung cancer risk in people under 45 and how risk factors may guide screening and therapeutic approaches; and Elliot Brea, MD, PhD, is exploring how a modified CAR T-cell therapy may be effective in treating non-small cell lung cancer.
-
A Message from Melany Duval
Because of your support for The Dana-Farber Campaign, our impact and growth will expand by an order of magnitude we have only begun to imagine.
-
One in a billion: Pan-Mass Challenge surpasses $1 billion fundraising milestone
In 2024, the Pan-Mass Challenge had a banner year, as the organization generated a record gift of $75 million and surpassed an extraordinary $1.047 billion in lifetime fundraising since its founding in 1980.
-
Faculty Research Fund sparks innovation
The Faculty Research Fund supports Dana-Farber priorities that transcend individual disciplines and facilitate breakthroughs across all cancer types.
-
Dr. Gerald and Mrs. Mary McGillicuddy
Dr. Gerald and Mrs. Mary McGillicuddy made a $100,000 gift to support the work of Julia Rotow, MD, a researcher in the Lowe Center for Thoracic Oncology at Dana-Farber. With this gift, Rotow and her team will work to develop better, more effective targeted and immunotherapy options for patients with lung cancer.
-
Leukemia & Lymphoma Society grants target blood cancers
The Leukemia & Lymphoma Society recently awarded more than $7.3 million in grants to Dana-Farber researchers in its quest to better understand and find cures for blood cancers.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.